Risk Factors of Drug Resistance and the Potential Risk of HIV-1 Transmission of Patients with ART Virological Failure: A Population-Based Study in Sichuan, China

References

• Union: AIDS. Available from: https://www.un.org/zh/sections/issues-depth/aids/index.html. Accessed March 22, 2020.
   Google Scholar
• Piot P, Bartos M, Ghys PD, et al. The global impact of HIV/AIDS. Nature. 2001;410(6831):968–973. doi:10.1038/3507363911309626
   PubMed Web of Science ®Google Scholar
• Cohen MS, Ying QC, Mccauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):1934–1935. doi:10.1056/NEJMoa1105243
   Web of Science ®Google Scholar
• Thompson MA, Aberg JA, Hoy JF, et al. Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel. JAMA. 2012;308(4). doi:10.1001/jama.2012.7961
   Web of Science ®Google Scholar
• Phillips AN, Cambiano V, Miners A, et al. Effectiveness and cost-effectiveness of potential responses to future high levels of transmitted HIV drug resistance in antiretroviral drug-naive populations beginning treatment: modelling study and economic analysis. BMC Infect Dis. 2014;1(2):e85–e93. doi:10.1016/S2352-3018(14)70021-9
   Web of Science ®Google Scholar
• Liao L, Xing H, Su B, et al. Impact of HIV drug resistance on virologic and immunologic failure and mortality in a cohort of patients on antiretroviral therapy in China. Aids. 2013;27(11):1815–1824. doi:10.1097/QAD.0b013e328361193123803794
   PubMed Web of Science ®Google Scholar
• Li X, Fang XD, Mao R, et al. HIV/STD risk behaviors and perceptions among rural-to-urban migrants in China. AIDS Educ Prev. 2004;16(6):538–556. doi:10.1016/j.physletb.2004.01.08415585430
   PubMed Web of Science ®Google Scholar
• Xiao C, Liu D, Jia P, et al. The changing modes of human immunodeficiency virus transmission and spatial variations among women in a minority prefecture in southwest China: an exploratory study. Medicine. 2020;99(6):e18776. doi:10.1097/MD.000000000001877632028390
   PubMed Web of Science ®Google Scholar
• Hassan AS, Pybus OG, Sanders EJ, et al. Defining HIV-1 transmission clusters based on sequence data. AIDS. 2017;31(9):1211–1222. doi:10.1097/QAD.000000000000147028353537
   PubMed Web of Science ®Google Scholar
• Jean LF, Domercant JW, Ignacio C, et al. High prevalence of HIV-1 drug resistance and dynamics of transmission among high-risk populations in Port-Au-Prince, Haiti. J Acquir Immune Defic Syndr. 2020;85(4):416–422. doi:10.1097/QAI.000000000000247533136738
   PubMed Web of Science ®Google Scholar
• Zheng M, Yu M, Cheng S, et al. Characteristics of HIV-1 molecular transmission networks and drug resistance among men who have sex with men in Tianjin, China (2014–2018). Virol J. 2020;17(1). doi:10.1186/s12985-020-01441-8
   Web of Science ®Google Scholar
• Jing W, Cui H, Hsi JH, et al. Virological outcomes and drug resistance in Chinese patients after 12 months of 3TC-based first-line antiretroviral treatment, 2011–2012. PLoS One. 2014;9(2):e88305. doi:10.1371/journal.pone.008830524516631
   PubMed Web of Science ®Google Scholar
• Kan W, Teng T, Liang S, et al. Predictors of HIV virological failure and drug resistance in Chinese patients after 48 months of antiretroviral treatment, 2008–2012: a prospective cohort study. BMJ Open. 2017;7(9):e16012. doi:10.1136/bmjopen-2017-016012
   Web of Science ®Google Scholar
• Yuan D, Liu M, Jia P, et al. Prevalence and determinants of virological failure, genetic diversity and drug resistance among people living with HIV in a minority area in China: a population-based study. BMC Infect Dis. 2020;20(1). doi:10.1186/s12879-020-05124-1
   Web of Science ®Google Scholar
• Namale G, Kamacooko O, Bagiire D, et al. Sustained virological response and drug resistance among female sex workers living with HIV on antiretroviral therapy in Kampala, Uganda: a cross-sectional study. Sex Transm Infect. 2019:2018–53854. doi:10.1136/sextrans-2018-053854
   Web of Science ®Google Scholar
• Gupta-Wright A, Fielding K, van Oosterhout JJ, et al. Virological failure, HIV-1 drug resistance, and early mortality in adults admitted to hospital in Malawi: an observational cohort study. Lancet HIV. 2020;7(9):e620–e628. doi:10.1016/S2352-3018(20)30172-732890497
   PubMed Web of Science ®Google Scholar
• Meriki HD, Tufon KA, Afegenwi MH, et al. Immuno-haematologic and virologic responses and predictors of virologic failure in HIV-1 infected adults on first-line antiretroviral therapy in Cameroon. Infect Dis Poverty. 2014;3(1):5. doi:10.1186/2049-9957-3-524479873
   PubMed Web of Science ®Google Scholar
• Yuan D, Du Z, Zhou J, et al. HIV-1 subtype diversity, drug resistance, and genetic transmission networks in men who have sex with men with virologic failure in antiretroviral therapy in Sichuan, China, 2011 to 2017. Medicine. 2019;98(43):e17585. doi:10.1097/MD.000000000001758531651864
   PubMed Web of Science ®Google Scholar
• Dong K, Ye L, Leng Y, et al. Prevalence of HIV-1 drug resistance among patients with antiretroviral therapy failure in Sichuan, China, 2010–2016. Tohoku J Exp Med. 2019;247(1):1–12. doi:10.1620/tjem.247.130643108
   PubMed Web of Science ®Google Scholar
• Zhang F, Pan J, Yu L, et al. Current progress of China’s free ART program. Cell Res. 2005;15(11):877–882. doi:10.1038/sj.cr.729036216354563
   PubMed Web of Science ®Google Scholar
• Wertheim JO, Kosakovsky Pond SL, Forgione LA, et al. Social and genetic networks of HIV-1 transmission in New York City. PLoS Pathog. 2017;13(1):e1006000. doi:10.1371/journal.ppat.100600028068413
   PubMed Web of Science ®Google Scholar
• Pang X, Wei H, Huang J, et al. Patterns and risk of HIV-1 transmission network among men who have sex with men in Guangxi, China. Sci Rep. 2021;11(1). doi:10.1038/s41598-020-79951-2
   Web of Science ®Google Scholar
• Arruda GD, Barbieri AL, Rodriguez PM, et al. Role of centrality for the identification of influential spreaders in complex networks. Phys Rev E Stat Nonlin Soft Matter Phys. 2014;90(3):32812. doi:10.1103/PhysRevE.90.032812
   Web of Science ®Google Scholar
• Werb D, Mills EJ, Montaner J, et al. Risk of resistance to highly active antiretroviral therapy among HIV-positive injecting drug users: a meta-analysis. Lancet Infect Dis. 2010;10(7):464–469. doi:10.1016/S1473-3099(10)70097-920610328
   PubMed Web of Science ®Google Scholar
• Xi C, Mo P, Jinghua L, et al. Factors associated with drug use among HIV-infected men who have sex with men in China. AIDS Behav. 2020;24(6):1612–1620. doi:10.1007/s10461-019-02660-z31486007
   PubMed Web of Science ®Google Scholar
• Chen L, His JH, Wu X, et al. Disparities in HIV and syphilis prevalence and risk factors between older male clients with and without steady sex partners in southwestern rural China. BMC Infect Dis. 2017;17(1):269. doi:10.1186/s12879-017-2367-z28403825
   PubMed Web of Science ®Google Scholar
• Su L, Feng Y, Liang S, et al. The origin and spread of CRF85_BC, driven by heterosexual transmission among older people in Sichuan, China. BMC Infect Dis. 2020;20(1). doi:10.1186/s12879-020-05488-4
   Web of Science ®Google Scholar
• Zhang F, Li L, Sun M, et al. An analysis of drug resistance among people living with HIV/AIDS in Shanghai, China. PLoS One. 2017;12(2):e165110. doi:10.1371/journal.pone.0165110
   Web of Science ®Google Scholar
• Huang L, Wu H, Yan H, et al. Syphilis testing as a proxy marker for a subgroup of men who have sex with men with a central role in HIV-1 transmission in Guangzhou, China. Front Med. 2021;8. doi:10.3389/fmed.2021.662689
   Web of Science ®Google Scholar
• Bulstra CA, Hontelez J, Giardina F, et al. Mapping and characterising areas with high levels of HIV transmission in sub-Saharan Africa: a geospatial analysis of national survey data. PLoS Med. 2020;17:e1003042. doi:10.1371/journal.pmed.100304232142509
   PubMed Web of Science ®Google Scholar
• Eshraghian EA, Ferdos SN, Mehta SR. The impact of human mobility on regional and global efforts to control HIV transmission. Viruses. 2020;12(1):67. doi:10.3390/v12010067
   Web of Science ®Google Scholar
• Han M. Forty years of fighting AIDS, we are on the road to ending the AIDS epidemic. Chinese J Exp Clin Virol. 2021;35(2):3. doi:10.3760/cma.j.cn112866-20210312-00046
   Google Scholar
• Ratmann O, Kagaayi J, Hall M, et al. Quantifying HIV transmission flow between high-prevalence hotspots and surrounding communities: a population-based study in Rakai, Uganda. Lancet HIV. 2020;7(3):e173–e183. doi:10.1016/S2352-3018(19)30378-931953184
   PubMed Web of Science ®Google Scholar
• Alirol EP, Getaz LM, Stoll BM, et al. Urbanisation and infectious diseases in a globalised world. Lancet Infect Dis. 2011;11(2):131–141. doi:10.1016/S1473-3099(10)70223-121272793
   PubMed Web of Science ®Google Scholar
• Lu X, Zhao H, Zhang Y, et al. HIV-1 drug-resistant mutations and related risk factors among HIV-1-positive individuals experiencing treatment failure in Hebei Province, China. AIDS Res Ther. 2017;14(1). doi:10.1186/s12981-017-0133-3
   Web of Science ®Google Scholar
• Yuan D, Liu M, Li Y, et al. Genetic transmission networks of HIV-1 CRF07_BC strain among HIV-1 infections with virologic failure of ART in a minority area of China: a population-based study. BMC Infect Dis. 2020;20(1). doi:10.1186/s12879-020-05347-2
   Web of Science ®Google Scholar